Albert Bourla

What better way to mark the two-year anniversary of “fifteen days to slow the spread” than by getting a fourth Covid shot? In an interview with CBS’s Face the Nation, Pfizer CEO Albert Bourla told Margaret Brennan, “Right now, the way that we have seen, it is necessary, a fourth booster right now.” Bourla, who made $17.9 million in 2019 before the pandemic, wasn’t even wearing a white lab coat as he made his diagnosis. No stethoscope from the studio prop room either. “The protection that you are getting from the third, it is good enough, actually quite good for hospitalizations and deaths. It’s not that good against infections, but doesn’t last very long.

The new Omicron variant of Covid-19 is “mild” and no reason to panic, according to one of the South African doctors who discovered the new strain. Nonetheless, American politicians and public health officials are extending mask mandates, expanding vaccine mandates, and warning of the potential for another lockdown. Pfizer is taking their cues and stepping in to play hero. Despite only having a week or two of research available to them, the pharmaceutical giant insists that preliminary lab results show that three doses of their vaccine work well at neutralizing the Omicron variant. How convenient that the so-called “booster” shot Pfizer and President Joe Biden have been pushing for months is now found to be super effective against this new variant.